The current role of immunotherapy in treating nasopharyngeal carcinoma.

Guo LF, Sun MJ, Li SY, Wu SG

Open source

DOI
10.1080/21645515.2026.2710439
Published
2026 Dec
Container
Human vaccines & immunotherapeutics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/21645515.2026.2710439,
  title = {The current role of immunotherapy in treating nasopharyngeal carcinoma.},
  author = {Guo LF and Sun MJ and Li SY and Wu SG},
  year = {2026},
  journal = {Human vaccines \& immunotherapeutics},
  doi = {10.1080/21645515.2026.2710439},
  url = {https://doi.org/10.1080/21645515.2026.2710439}
}

RIS

TY  - JOUR
TI  - The current role of immunotherapy in treating nasopharyngeal carcinoma.
AU  - Guo LF
AU  - Sun MJ
AU  - Li SY
AU  - Wu SG
PY  - 2026
JO  - Human vaccines & immunotherapeutics
DO  - 10.1080/21645515.2026.2710439
UR  - https://doi.org/10.1080/21645515.2026.2710439
ER  - 

APA

LF, G., MJ, S., SY, L., & SG, W. (2026). The current role of immunotherapy in treating nasopharyngeal carcinoma.. Human vaccines & immunotherapeutics. https://doi.org/10.1080/21645515.2026.2710439

Source records